Correlation Between United Therapeutics and Liquidia Technologies
Can any of the company-specific risk be diversified away by investing in both United Therapeutics and Liquidia Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining United Therapeutics and Liquidia Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between United Therapeutics and Liquidia Technologies, you can compare the effects of market volatilities on United Therapeutics and Liquidia Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in United Therapeutics with a short position of Liquidia Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of United Therapeutics and Liquidia Technologies.
Diversification Opportunities for United Therapeutics and Liquidia Technologies
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between United and Liquidia is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding United Therapeutics and Liquidia Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Liquidia Technologies and United Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on United Therapeutics are associated (or correlated) with Liquidia Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Liquidia Technologies has no effect on the direction of United Therapeutics i.e., United Therapeutics and Liquidia Technologies go up and down completely randomly.
Pair Corralation between United Therapeutics and Liquidia Technologies
Given the investment horizon of 90 days United Therapeutics is expected to under-perform the Liquidia Technologies. But the stock apears to be less risky and, when comparing its historical volatility, United Therapeutics is 1.98 times less risky than Liquidia Technologies. The stock trades about -0.1 of its potential returns per unit of risk. The Liquidia Technologies is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest 1,246 in Liquidia Technologies on November 9, 2024 and sell it today you would earn a total of 350.00 from holding Liquidia Technologies or generate 28.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
United Therapeutics vs. Liquidia Technologies
Performance |
| Timeline |
| United Therapeutics |
| Liquidia Technologies |
United Therapeutics and Liquidia Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with United Therapeutics and Liquidia Technologies
The main advantage of trading using opposite United Therapeutics and Liquidia Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if United Therapeutics position performs unexpectedly, Liquidia Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Liquidia Technologies will offset losses from the drop in Liquidia Technologies' long position.| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
| Liquidia Technologies vs. Biomarin Pharmaceutical | Liquidia Technologies vs. Vaxcyte | Liquidia Technologies vs. Legend Biotech Corp | Liquidia Technologies vs. Bio Techne Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |